If you liked this article you might like

Drugmakers Plan Big Deals in 2017 -- and Banks Will Collect Big Fees
Is It Time to Buy Beaten-Down Bristol-Myers Squibb Stock?
Allergan, Apple, Facebook: Doug Kass' Views
Bristol-Myers Squibb, Merck, Synergy Pharmaceuticals: Doug Kass' Views